Gilbert & Cook, Inc. Eli Lilly & CO Transaction History

Gilbert & Cook, Inc.

$718 Million
Q3 2024

A detailed history of Gilbert & Cook, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gilbert & Cook, Inc. holds 1,743 shares of LLY stock, worth $1.34 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,743

Previous 1,757 0.8%

Holding current value

$1.34 Million

Previous $1.59 Million 2.89%

% of portfolio

0.22%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $10,809 - $13,440	-14 Reduced 0.8%	1,743 $1.54 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $5,329 - $7,130	9 Added 0.51%	1,757 $1.37 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $42,540 - $50,149	-81 Reduced 4.43%	1,748 $1.02 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $640,747 - $883,368	-1,474 Reduced 44.63%	1,829 $982,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $158,885 - $212,447	-453 Reduced 12.06%	3,303 $1.55 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $170,535 - $200,286	-549 Reduced 12.75%	3,756 $1.29 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $46,946 - $54,701	-146 Reduced 3.28%	4,305 $1.57 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $75,898 - $86,494	256 Added 6.1%	4,451 $1.58 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $213,785 - $251,016	-767 Reduced 15.46%	4,195 $1.36 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $123,212 - $153,121	525 Added 11.83%	4,962 $1.42 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $136,708 - $169,656	608 Added 15.88%	4,437 $1.23 Million
Q3 2021 Jan 20, 2022	BUY	$221.6 - $272.71 $767,400 - $944,394	3,463 Added 946.17%	3,829 $885,000
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $494,832 - $608,961	-2,233 Reduced 85.92%	366 $885,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $326,795 - $422,707	-1,810 Reduced 41.05%	2,599 $597,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $54,554 - $70,623	332 Added 8.14%	4,409 $824,000
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $172,337 - $228,044	1,321 Added 47.93%	4,077 $687,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $16,522 - $19,111	113 Added 4.28%	2,756 $408,000
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $114,319 - $137,582	838 Added 46.43%	2,643 $434,000
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $6,547 - $8,104	55 Added 3.14%	1,805 $250,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $187,110 - $231,752	1,750 New	1,750 $230,000
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $184,908 - $215,835	-1,669 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $185,776 - $218,672	1,669 New	1,669 $216,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.

Account